CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 252 filers reported holding CONMED CORP in Q2 2021. The put-call ratio across all filers is 8.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $14,161,683 | -24.0% | 140,423 | +2.4% | 0.31% | -19.0% |
Q2 2023 | $18,626,878 | +13.4% | 137,073 | -13.3% | 0.38% | +8.3% |
Q1 2023 | $16,420,906 | +26.7% | 158,106 | +8.1% | 0.35% | +25.4% |
Q4 2022 | $12,959,710 | +9.6% | 146,206 | -0.9% | 0.28% | -0.4% |
Q3 2022 | $11,829,000 | -10.5% | 147,549 | +6.8% | 0.28% | -4.1% |
Q2 2022 | $13,224,000 | -28.3% | 138,091 | +11.2% | 0.29% | -18.2% |
Q1 2022 | $18,443,000 | +2.3% | 124,155 | -2.4% | 0.36% | +4.4% |
Q4 2021 | $18,029,000 | +7.9% | 127,180 | -0.4% | 0.34% | +0.3% |
Q3 2021 | $16,706,000 | +3.4% | 127,693 | +8.6% | 0.34% | +4.3% |
Q2 2021 | $16,163,000 | +15.9% | 117,610 | +10.1% | 0.33% | +3.8% |
Q1 2021 | $13,951,000 | +156.1% | 106,830 | +119.6% | 0.32% | +133.3% |
Q4 2020 | $5,448,000 | +49.7% | 48,645 | +5.2% | 0.14% | +36.4% |
Q3 2020 | $3,639,000 | +35.1% | 46,260 | +23.7% | 0.10% | +28.6% |
Q2 2020 | $2,693,000 | +580.1% | 37,410 | +441.4% | 0.08% | +492.3% |
Q1 2020 | $396,000 | – | 6,910 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthCor Management, L.P. | 27,500 | $2,437,600 | 2.23% |
Ranger Investment Management | 316,318 | $28,038,428 | 2.08% |
Lighthouse Investment Partners, LLC | 142,100 | $12,595,744 | 1.39% |
Lighthouse Investment Partners, LLC | 139,200 | $12,338,688 | 1.36% |
EARNEST PARTNERS LLC | 2,402,352 | $212,944,481 | 1.30% |
Lighthouse Investment Partners, LLC | 108,200 | $9,590,848 | 1.06% |
MOODY ALDRICH PARTNERS LLC | 51,885 | $4,599,086 | 0.93% |
MOUNTAIN PACIFIC INVESTMENT ADVISERS INC/ID | 125,435 | $11,118,558 | 0.81% |
Champlain Investment Partners, LLC | 1,275,910 | $113,096,662 | 0.72% |
EPIQ PARTNERS, LLC | 10,463 | $927,440 | 0.62% |